NIH-funded research NIH-funded research

Translating new treatments for brain tumors

Official title: SPORE for Translational Approaches to Brain Cancer

Funded at Northwestern University · NIH-11187066 · Data updated 2026-11-12

This program brings doctors and researchers together to create and test new treatment options for people with glioblastoma and other brain tumors.

More Brain Cancer research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionNorthwestern University
NIH-funded
Lab location1 site (Chicago, United States)
Project startAugust 17, 2018
Project endJuly 31, 2028
Funding year2025
Award (this year)$2,140,963
NIH project number5P50CA221747-08
Project IDNIH-11187066 on NIH RePORTER

Who could benefit from this research

Could help

People with glioblastoma or other primary brain tumors who are treated at or can travel to Northwestern and who may be eligible for clinical trials or tissue donation.

Less likely to help

Individuals without primary brain tumors or those unable to access Northwestern or its affiliated trial sites are unlikely to receive direct benefit from this program.

What this research studies

From a patient point of view, a multidisciplinary team at Northwestern combines surgery, drug development, immune therapies, and laboratory studies to turn lab findings into treatments you could access. They collect tumor samples and clinical information, run lab and animal work to find promising approaches, and advance the most hopeful therapies into early clinical trials. Several projects run in parallel so discoveries can move more quickly from the lab to patients. If you have a brain tumor, this program aims to expand the treatment and trial options available at Northwestern.

Why it matters

Potential benefit: Could produce new clinical trials and treatments that improve survival and quality of life for people with brain tumors.

How similar studies have gone: Previous SPORE and translational programs have generated promising clinical trials for brain cancer, but glioblastoma remains challenging and many approaches are still experimental.

Where this research is happening

  • Northwestern University
    Chicago, United States
    Active

Researchers

  • Principal investigator: Lesniak, Maciej S — Northwestern University
  • Study coordinator: Lesniak, Maciej S

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.